KEYNOTE-564: A phase 3, randomized, double blind, trial of pembrolizumab in the adjuvant treatment of renal cell carcinoma.
Conference Paper
Full Text
Duke Authors
Cited Authors
- Choueiri, TK; Quinn, DI; Zhang, T; Gurney, H; Doshi, GK; Cobb, PW; Parnis, F; Lee, J-L; Park, SH; Semenov, A; Chang, WY-H; Wan, SM; Poehlein, CH; Powles, T
Published Date
- May 20, 2018
Published In
Volume / Issue
- 36 / 15_suppl
Start / End Page
- TPS4599 - TPS4599
Published By
Electronic International Standard Serial Number (EISSN)
- 1527-7755
International Standard Serial Number (ISSN)
- 0732-183X
Digital Object Identifier (DOI)
- 10.1200/jco.2018.36.15_suppl.tps4599